Henry Schein (NASDAQ:HSIC) Upgraded at Bank of America

Bank of America upgraded shares of Henry Schein (NASDAQ:HSIC) from an underperform rating to a buy rating in a report released on Monday morning, Marketbeat reports. The brokerage currently has $84.00 price target on the stock, up from their previous price target of $69.00.

Other equities research analysts have also issued research reports about the stock. Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Evercore ISI increased their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Barrington Research reaffirmed an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research report on Wednesday, November 6th. Finally, StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Seven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $79.40.

Henry Schein Stock Down 0.9 %

Shares of NASDAQ:HSIC opened at $71.06 on Monday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a 52-week low of $63.67 and a 52-week high of $82.63. The business’s 50 day simple moving average is $72.13 and its two-hundred day simple moving average is $70.37. The firm has a market cap of $8.86 billion, a P/E ratio of 29.24, a PEG ratio of 2.30 and a beta of 0.89.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s quarterly revenue was up .4% compared to the same quarter last year. During the same period last year, the business earned $1.32 EPS. As a group, research analysts forecast that Henry Schein will post 4.78 EPS for the current fiscal year.

Insider Buying and Selling

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.14% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. ING Groep NV purchased a new stake in Henry Schein in the 3rd quarter worth about $63,226,000. Holocene Advisors LP purchased a new position in shares of Henry Schein in the third quarter worth about $58,319,000. Thompson Siegel & Walmsley LLC bought a new stake in shares of Henry Schein in the second quarter valued at approximately $46,683,000. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Henry Schein during the 3rd quarter valued at approximately $43,740,000. Finally, Southpoint Capital Advisors LP boosted its holdings in Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after buying an additional 600,000 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.